Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 9,902 | 12,049 | 13,552 | 5,587 | 2,888 |
| Operating Income | -9,902 | -12,049 | -13,552 | -5,587 | -2,888 |
| Interest Expense | 0 | 0 | 45 | 1,186 | 1 |
| Other Income | -308 | 1,942 | 1,257 | 2,732 | 61 |
| Pre-tax Income | -10,210 | -10,107 | -12,340 | -4,041 | -2,828 |
| Net Income Continuous | -10,210 | -10,107 | -12,340 | -4,041 | -2,828 |
| Net Income | $-10,210 | $-10,107 | $-12,340 | $-4,041 | $-2,828 |
| EPS Basic Total Ops | -0.54 | -0.74 | -1.07 | -0.65 | -0.51 |
| EPS Basic Continuous Ops | -0.55 | -0.74 | -1.07 | -0.65 | -0.51 |
| EPS Diluted Total Ops | -0.54 | -0.74 | -1.07 | -0.65 | -0.51 |
| EPS Diluted Continuous Ops | -0.55 | -0.74 | -1.07 | -0.65 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.83 | -1.07 | -0.65 | N/A |
| EBITDA(a) | $-9,880 | $-12,028 | $-13,463 | $-5,584 | $-2,885 |